Kin Meds vs ShedRx
Kin Meds and ShedRx both sell semaglutide, tirzepatide and orforglipron; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Kin Meds and ShedRx, price alone will not settle it. Both prescribe semaglutide, tirzepatide and orforglipron, so moving from one to the other would not change your drug. Kin Meds leads our six-part score, 6.5 to 6.4. One of the two has an FDA warning letter on record, covered below.
Kin Meds vs ShedRx price
Kin Meds and ShedRx start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $149 a month; tirzepatide is cheaper at Kin Meds ($149 a month vs $299 a month); orforglipron costs the same at both, $149 a month.
Medications and formats
Both sell semaglutide, tirzepatide and orforglipron.
On format, Kin Meds prices compounded injections and brand-name pens, while ShedRx prices compounded injections and an oral option.
If you want the FDA-approved brand rather than a compounded version, Kin Meds is the only one of the two with a brand-name price.
Where each one treats patients
Neither Kin Meds nor ShedRx publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Kin Meds
$53 off first order, applied automatically at checkout per kinmeds.com/glp1-discount ('Save $53 on first order -Discount applied at checkout')
$53 off first order, auto-applied; discount page quotes starting dose 'as low as $49/week' first month
Kin Meds advertises "Starting at $149/mo" for Wegovy injection, Wegovy pill, Zepbound KwikPen, Zepbound vial and Foundayo alike. The price carries a footnote marker, but the footnote itself is missing from the site, so its conditions are unstated. Compounded semaglutide is $199 and tirzepatide $249.
Entry pricing — likely insured/savings-card tier; cash-pay LillyDirect vials run $299-$449/mo
Matches the LillyDirect $149/mo starter cash price for Foundayo
ShedRx
$199 on a 1-month plan, $179 on 6 months, $159 on 12 months. The lower figure is the 12-month commitment rate, not a temporary promo.
Starting at $229/month with medication, supplies, member support and free shipping included. Up from $199 earlier.
Starting at $199/month, month-to-month; free shipping stated (replaces our obsolete 'Oral $349' row)
$299 on a 1-month plan, $269 on 6 months, $239 on 12 months (the 12-month commitment rate).
NEW product. $149/mo medication (cash pay, paid to dispensing pharmacy) + $125/mo Shed membership and provider fee
Page shows BOTH: FAQ 'starts at $149 (pill) and $199 (pen)... new patients using cash pay' + '$99 Shed membership', while hero states '$349-499 for the medication' + '$125/month Shed Membership'. Medication purchased directly via NovoCare; membership fee inconsistency ($99 vs $125) on same page
FAQ: 'starts at $349 per month for new patients using cash pay' + $99 membership per FAQ ($125/mo per hero); medication purchased directly via LillyDirect
Starting at $169/month; 'Includes 2 Health Coaching sessions per month'
What each price covers
ShedRx's price also covers the clinician visit, the medication itself and coaching, which Kin Meds does not claim.
Kin Meds does not say what its price includes.
ShedRx is silent on shipping and lab work.
That matters most for the drug: unless Kin Meds confirms otherwise, budget for medication on top of its listed price.
Kin Meds
Inclusions not disclosed.
ShedRx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Kin Meds scores 6.5 and ShedRx 6.4 out of 10.
Kin Meds is stronger on user experience (8.0 vs 3.0).
ShedRx is stronger on value (6.5 vs 5.0), trust & safety (4.0 vs 3.5) and support (7.0 vs 5.0).
Effectiveness and accessibility are within half a point.
Kin Meds
6.5/10
ShedRx
6.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Kin Meds a warning letter dated February 20, 2026 (letter 721450), and it is still open.
ShedRx has no FDA warning letter on record with us.
Features & Coverage
| Feature | Kin Meds | ShedRx |
|---|---|---|
| Starting Price | $149/mo | $149/mo |
| Features | ✓8 features | 4 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Kin Meds
Kin Meds starts compounded semaglutide at $199/mo and compounded tirzepatide at $249/mo, and carries brand-name FDA-approved options including Wegovy injection and pill, Zepbound and Foundayo from $149/mo. It is LegitScript-verified. Beyond weight loss the account also covers Sermorelin, NAD+, glutathione, TRT, hair, skin and sexual health, so members can run several protocols in one place.
Read our full Kin Meds review →About ShedRx
ShedRx is a telehealth seller with three formats of compounded GLP-1 medication: drops, lozenges, and injections.
Read our full ShedRx review →Pros & Cons
Kin Meds
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Kin Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
ShedRx
What we like
- Semaglutide costs $149 a month, 19% below the $184 median for compounded semaglutide across the sellers we compare
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to ShedRx
- Offers both oral and injectable options, so the format is your choice
Watch-outs
- Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
ShedRx is where we would start, above all for oral orforglipron alongside the injectables. Kin Meds fits better if oral orforglipron alongside the injectables is your priority.
Choose Kin Meds if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose ShedRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Kin Meds vs ShedRx: FAQ
Close alternatives to Kin Meds and ShedRx
- Kin Meds vs Found
- Kin Meds vs PreventiveMD
- Kin Meds vs Sesame Care
- ShedRx vs Found
- ShedRx vs Sesame Care
- ShedRx vs Maximus
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.